Eagle Pharmaceuticals Inc... (EGRX)
OTC: EGRX
· Real-Time Price · USD
1.25
-0.25 (-16.67%)
At close: Apr 04, 2025, 3:30 PM
Eagle Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 5.16M | 5.75M | 8.16M | -3.51M | -9.45M | 44.06M | -6.2M | -5.62M | 3.61M | -421K |
Depreciation & Amortization | 5.58M | 5.56M | 5.63M | 3.85M | 1.63M | 908K | 1.07M | 903K | 894K | 896K |
Stock-Based Compensation | 4.19M | 4.64M | 4.12M | 3.54M | 4.5M | 4.29M | 4.68M | 4.08M | 4.28M | 6.51M |
Other Working Capital | -13.7M | -7.3M | -8.84M | -548K | 535K | 28.51M | 9.51M | -5.15M | 4.91M | -5.59M |
Other Non-Cash Items | 954K | 772K | -5.88M | 7.64M | 401K | 2.32M | 4.8M | 2.62M | 5.33M | -5.13M |
Deferred Income Tax | -1.78M | -2.18M | -3.58M | -298K | -2.01M | -2.43M | -1.08M | -3.65M | 217K | 902K |
Change in Working Capital | -14.23M | -48.05M | 29.11M | -24.46M | 44.71M | -65.76M | 4.82M | 2.74M | -5.74M | 7.72M |
Operating Cash Flow | -126K | -33.51M | 37.56M | -13.24M | 42.99M | -16.61M | 8.08M | 1.07M | 8.59M | 10.48M |
Capital Expenditures | -6K | -58K | -10K | n/a | n/a | -168K | -49K | -5K | 115K | -384K |
Cash Acquisitions | n/a | n/a | 1K | 1.26M | -75.42M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -12.5M | -12.5M | -12.5M | n/a | n/a | n/a | n/a | 5M | -5M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -12.5M | 12.5M | -12.5M | n/a | n/a | n/a | n/a | -5M | -5M |
Investing Cash Flow | -6K | -12.56M | -9K | -11.24M | -75.42M | -168K | -49K | -5K | 115K | -5.38M |
Debt Repayment | -6.25M | 13.75M | 3.76M | 13M | -2M | -2M | -2M | -2M | -2M | -2M |
Common Stock Repurchased | -161K | -1.1M | -15K | -9.95M | -36K | -8.05M | -8.64M | -8.27M | -2.87M | -1.43M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -161K | -1.1M | -1.38M | 247K | 1.46M | -1.3M | 531K | 233K | -355K | 412K |
Financial Cash Flow | -6.41M | 12.65M | 2.39M | 3.3M | -536K | -11.36M | -10.11M | -10.04M | -5.22M | -3.02M |
Net Cash Flow | -6.54M | -33.42M | 39.94M | -21.18M | -32.96M | -28.14M | -2.08M | -8.98M | 3.49M | 2.07M |
Free Cash Flow | -132K | -33.57M | 37.55M | -13.24M | 42.99M | -16.78M | 8.03M | 1.06M | 8.71M | 10.09M |